Kusajili – Clinical trials directory

Result of your search per sponsor: Jeffrey S A Stringer, MD

Woman Max 99 years
Jeffrey S A Stringer, MD Update Il y a 4 ans

Maternal TDF and FTC to Reduce NNRTI Resistance Mutations After Intrapartum NVP The purpose of this study is to determine whether the addition of tenofovir (TDF) and emtricitabine (FTC)to a standard PMTCT regimen containing single-dose nevirapine (NVP) can reduce the ...

Country Zambia
organs None
Specialty None

Closed trial

More information